Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The staging of soft-tissue sarcomas.

B Rööser1, R Attewell, A Rydholm

  • 1Department of Orthopaedics, University Hospital, Lund, Sweden.

International Orthopaedics
|January 1, 1987
PubMed
Summary

Current soft-tissue sarcoma staging systems struggle to differentiate patient survival outcomes. Multivariate analysis of prognostic factors is recommended for developing more effective staging systems for these tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simple guidelines for efficient referral of soft-tissue sarcomas: a population-based evaluation of adherence to guidelines and referral patterns.

The Journal of bone and joint surgery. American volume·2012
Same author

Nonrandom secondary chromosome-aberrations in liposarcomas with t(12, 16).

International journal of oncology·2011
Same author

Nonrandom secondary chromosome-aberrations in synovial sarcomas with t(x-18).

International journal of oncology·2011
Same author

Deep-seated ordinary and atypical lipomas: histopathology, cytogenetics, clinical features, and outcome in 215 tumours of the extremity and trunk wall.

The Journal of bone and joint surgery. British volume·2008
Same author

Chest wall sarcoma: outcome in 22 patients after resection requiring thoracic cage reconstruction.

Sarcoma·2008
Same author

Treatment of Paget's disease of bone: a survey of clinical practice in Australia.

Bone·2008

Area of Science:

  • Oncology
  • Surgical Pathology
  • Biostatistics

Background:

  • Accurate prognostic staging is crucial for managing soft-tissue sarcoma (STS).
  • Existing staging systems include the American Joint Committee (AJCC) System, Hajdu, and Surgical Staging System.
  • The effectiveness of these systems in stratifying STS patient prognosis requires evaluation.

Purpose of the Study:

  • To assess the ability of three established staging systems to differentiate prognostic groups in patients with soft-tissue sarcoma.
  • To identify limitations of current staging systems in predicting overall survival for nonmetastatic STS.
  • To advocate for improved methodologies in STS staging system development.

Main Methods:

  • Retrospective analysis of 122 patients with nonmetastatic soft-tissue sarcoma of the locomotor system.
  • All patients underwent wide or radical surgical margin resection.
  • Evaluation of the discriminatory power of the AJCC, Hajdu, and Surgical Staging Systems regarding overall survival.

Main Results:

  • None of the evaluated staging systems could reliably distinguish more than two distinct prognostic groups.
  • Significant differences in overall survival were limited across the strata defined by these systems.
  • The current systems showed insufficient granularity for precise prognostic stratification in this cohort.

Conclusions:

  • The American Joint Committee System, Hajdu, and Surgical Staging System demonstrate limited ability to separate prognostic groups for soft-tissue sarcoma.
  • There is a need for more sophisticated approaches to staging soft-tissue sarcoma.
  • Multivariate analysis of prognostic factors is essential for constructing improved and more accurate staging systems for soft-tissue sarcoma.

Related Experiment Videos